Acta clinica Croatica, Vol. 49 No. 3, 2010.
First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST)
Marko Boban orcid.org/0000-0002-6129-575X
Full text: english pdf 213 Kb
APA 6th Edition
Nikolić, M., Boban, M., Ljubičić, N., Bekavac-Bešlin, M., Tomas, D., Pezo-Nikolić, B., ... Žokvić, E. (2010). First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST). Acta clinica Croatica, 49 (3), 359-363. Retrieved from https://hrcak.srce.hr/84765
MLA 8th Edition
Nikolić, Marko, et al. "First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST)." Acta clinica Croatica, vol. 49, no. 3, 2010, pp. 359-363. https://hrcak.srce.hr/84765. Accessed 29 Mar. 2023.
Chicago 17th Edition
Nikolić, Marko, Marko Boban, Neven Ljubičić, Miroslav Bekavac-Bešlin, Davor Tomas, Borka Pezo-Nikolić, Tomislav Kuliš, Aljoša Matejčić, Davor Hrabar and Edita Žokvić. "First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST)." Acta clinica Croatica 49, no. 3 (2010): 359-363. https://hrcak.srce.hr/84765
Nikolić, M., et al. (2010). 'First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST)', Acta clinica Croatica, 49(3), pp. 359-363. Available at: https://hrcak.srce.hr/84765 (Accessed 29 March 2023)
Nikolić M, Boban M, Ljubičić N, Bekavac-Bešlin M, Tomas D, Pezo-Nikolić B, et al. First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST). Acta clinica Croatica [Internet]. 2010 [cited 2023 March 29];49(3):359-363. Available from: https://hrcak.srce.hr/84765
M. Nikolić, et al., "First Report of Connexin 43-Positive Gastrointestinal Stromal Tumor (GIST)", Acta clinica Croatica, vol.49, no. 3, pp. 359-363, 2010. [Online]. Available: https://hrcak.srce.hr/84765. [Accessed: 29 March 2023]
Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms most frequently found in the stomach and presenting without symptoms or with unspecific ones such as hemorrhage and abdominal pain. The malignant potential of GIST is variable and there are several prognostic indexes for treatment and follow up. The superior diagnostic method is endoscopic ultrasound combined with fine needle aspiration biopsy (EUS-FNA) immunocytochemistry. Surgery is the preferable treatment option, while recurrent or advanced disease is best managed with thyrosine kinase inhibitors. We report a case of a 20-year-old man that presented with gastrointestinal bleeding and anemia. Upper gastrointestinal endoscopy detected a submucosal lesion and computerized tomography revealed a node near the liver. EUS-FNA immunocytochemistry found CD-117 positive cells suggestive of GIST and the patient was operated on. The diagnosis was confirmed by histopathology with immunostaining. Prognostic assessment was done according to tumor size and Ki-67 index with mitosis count on microscopy. Many studies have shown that tumors demonstrate an abnormal number, structure and occurrence of connexin proteins with altered connexin-mediated intercellular communication. Since a great deal of gastroenterological tumors express connexin 43, our aim was to find out whether it was present in GIST. Immunohistochemically, the tumor was positive for connexin 43, which was not previously described as typical. The early postoperative course was uneventful, free from complications. At three-year postoperative follow-up, the patient was subjectively well and without clinical signs of disease recurrence.
Gastrointestinal stromal tumors – diagnosis, Gastrointestinal stromal tumors – pathology, Neoplasms, Connexin 43, Immunohistochemistry
Visits: 4.852 *